ReviewAdvances in neurobiology2024

Mismatch Negativity (MMN) as a Pharmacodynamic/Response Biomarker for NMDA Receptor and Excitatory/Inhibitory Imbalance-Targeted Treatments in Schizophrenia.

Daniel C JavittPubMed ↗Publisher ↗

No numbers read from the abstract.